Patient Details:

Patient ID:   p003_GEA_C1_2
Age:   -
Gender:   -
Cancer Description:   -
Sample Location:   primary in stomach and metasis in asites
Tumor Stage:   -
TNM Stage:   -
Treatment:
    Treatment schema: patients with untreated metastatic GEA are assigned to a combination of FOLFOX chemotherapy and distinct targeted therapies including trastuzumab (anti-ERBB2), ABT-806 (anti-EGFR), ramucirumab (anti-VEGFR2) or nivolumab (anti-PD1). Patients in the planned MET and FGFR3 inhibitor arms have, to date, been treated with FOLFOX due to lack of targeted drug availability.
Tumor Purity:
    metastasis:0.53; primary purity:0.18; Software: ABSOLUTE
Supported Literature:

Sample Sequencing:   Whole exome sequencing
PMID:   28978556
Data Sources:   Fig.1 and Fig.2
Journal:   Cancer Discov
Published:   2018 Jan
Sequencing Platform:   Illumina HiSeq
Pipeline/Software:   mutation calling:MuTect v1.1.4; annotation: Variant Effector Predictor;
Sample Region:

Sample Region:

●The samples from a single patient are used to generate phylogenetic tree.
●The schematic diagram is adapted from the original figure in the article.

Phylogenetic Tree:

Phylogenetic tree:

●Trunk mutation: Alterations shared by all samples/regions, possibly occurred early in tumorigenesis.
Branch mutation: Alterations shared by a subset of samples or regions, possibly occurred later in tumorigenesis.
Private mutation: Alterations present in only one sample/region of the tumor, possibly occurred later in tumorigenesis.
●Branch lengths are proportional to the number of mutations separating the branching points.
●Potential driver genes/mutations are mapped along the tree if available.

Mutation Heatmap

●Somatic mutation landscape of cancer related genes in the study.
●Each row represents one patient; each column represents one cancer gene.
●The heat map indicates the presence and classification of a mutation or its absence (gray) in each patient.

Gene Lists Analysis:
    Visualizations of meta-analysis results based on multiple trunk mutation gene lists

-log10(P)

●Heatmap of the top enrichment clusters, generated by the trunk mutation gene list of each patient in the study.
●Each row represents one cluster; each column represents one patient.
●The discrete color scale represents statistical significance.

●The Circos plot shows the functional overlaps of genes that share the same ontology term.
●The arc annotation is the same as in the left Circos plot.
●Blue lines link the different genes where they fall into the same ontology term.

●The Circos plot shows the overlap of the trunk mutation gene list of each patient.
●Each outside arc represents the identity of a gene list; each gene is represented as a spot on the inside arc.
●For the inside arc, dark orange represents the genes that appear in multiple lists; light orange represents the genes that are unique to that gene list.
●Purple lines link the same gene that shared by multiple gene lists.

●Enrichment network visualization for results from the multiple trunk mutation gene lists in one study.
●Each term is represented by a circle node, where its size is proportional to the number of input genes fall into that term, and the color represents its cluster identity.
●The edge links terms with high similarity; the thickness of the edge represents the degree of similarity.
●Click the picture, more details of the network by cluster can be illustrated.


●The same enrichment network as the above network figure, and has its nodes displayed as pies.
●Each pie sector is proportional to the number of hits originated from a gene list.
●The color code represents the identities of trunk mutation gene lists.
●Click the picture, more details of the network by counts can be illustrated.

© 2019 Cai Laboratory